Ready to accelerate your clinical trial? Visit bioaccess® →
Global Trial Accelerators™
Global Trial Accelerators™
Accelerate Your Path from First-in-Human to Exit Hosted by Jesús E. Moreno (Business Development Director, bioaccess®), Global Trial Accelerators™ is the only podcast for healthcare startup founders and innovators navigating first-in-human (FIH) clinical trials. The show is produced by bioaccess® and was founded by Co-Founder & CEO Julio G. Martinez-Clark. bioaccess® is a CRO purpose-built for first-in-human (FIH) trials — serving MedTech, Biopharma, and Radiopharma startups. This podcast delivers strategies, regulatory insights, and founder stories to get your technology into humans faster and affordably, with data designed to support FDA and EMA submissions. Each episode features candid conversations with clinical trial pioneers, regulatory strategists, and founders who've compressed timelines, reduced costs, and generated the clinical evidence investors demand — by leveraging the Americas' clinical research infrastructure, from Canada to Argentina. What You'll Learn: - Regulatory pathways across 10+ Latin American countries (Colombia, Mexico, Brazil, Chile, Argentina, Panama, Ecuador, El Salvador, Dominican Republic, Paraguay) - Why ethics approval in 4-8 weeks (vs. 6-12 months in US/EU) changes the game for startups - Strategies to generate FIH data that unlocks your next funding round or acquisition - The Innovation Runway: from prototype to clinical milestones before capital runs out - Case studies from 58+ companies — seed-stage startups to Fortune 500 MedTech - Decentralized trials, AI-driven recruitment, and post-trial commercialization "bioaccess® compressed our timeline by 9 months vs. our US plan. This podcast is why we partnered with them." – Digital Health Startup CEO New episodes weekly. Subscribe to unlock your shortcut from first-in-human to exit. Brought to you by bioaccess® — an FIH-dedicated CRO for healthcare startups. Faster timelines, lower costs. Since 2010.
Choose your favorite podcast player
Oct. 23, 2024

Paulo Fernandes, C2O Fundador & Principal

Paulo Fernandes is a distinguished clinical research executive with extensive experience in international clinical trials across various phases and therapeutic areas. With a solid foundation in the CRO industry, he has successfully held roles in project management, start-up, operations management, and business development. Paulo has worked at renowned CROs such as PPD, Covance, and IQVIA. Recently, he structured a healthcare sector start-up for a group of investors, showcasing his entrepreneurial spirit and commitment to high-impact public health initiatives. Additionally, he has 10 years of experience at the Brazilian Association of Clinical Research Organizations, including 4 years as the President of the Board of Directors. Paulo holds a specialization in Clinical Pharmacology from USCS, a degree in Pharmacy and Biochemistry from FCF-USP, and training in Business and Project Management from FIA, along with an Executive MBA from INSPER.

Related to this Episode

Navigating the World of International Clinical Trials: Insights from Paulo Fernandes

Welcome to the blog! In today's globalized world, clinical trials are increasingly conducted across borders, presenting both incredible opportunities and significant challenges. Understanding the intricacies of international clinical research is cru…

The Brazilian Clinical Research Landscape: A Conversation with Paulo Fernandes

Welcome to this blog post, a deep dive into the dynamic world of clinical research in Brazil. In this article, we'll be exploring the unique challenges, opportunities, and the crucial role of industry associations in shaping the clinical research la…